Art

J-GLOBAL ID：202002280979448654   Reference number：20A2687008

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study

壊疽性膿皮症の活動性潰瘍を有する日本人患者におけるアダリムマブ:26週間の第3相非盲検試験

Author (7)： Yamasaki Kenshi (Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan) ,  Yamanaka Keiichi (Department of Dermatology, Graduate School of Medicine, Mie University, Tsu, Japan) ,  Zhao Yiwei (AbbVie Inc., Cambridge, Massachusetts, USA) ,  Iwano Shunsuke (AbbVie GK, Tokyo, Japan) ,  Takei Keiko (AbbVie GK, Tokyo, Japan) ,  Suzuki Koji (AbbVie GK, Tokyo, Japan) ,  Yamamoto Toshiyuki (Department of Dermatology, Fukushima Medical University School of Medicine, Fukushima, Japan)
Material： Journal of Dermatology  (J Dermatol)
Volume： 47  Issue： 12  Page： 1383-1390  Publication year： Dec. 2020 
JST Material Number： W1578A  ISSN： 0385-2407  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Adalimumab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2687008&from=J-GLOBAL&jstjournalNo=W1578A") }}

Author keywords (5)： adalimumab ,  Japanese patient ,  pyoderma gangrenosum ,  skin ulcer ,  tumor necrosis factor-α

JST classification (3)： Clinical application of drugs acting on integumentum commune  (GW12020J) ,  Skin diseases  (GF03000Q) ,  Drug therapy(=pharmacotherapy)for skin diseases  (GF05020A)

Terms in the title (8)： 壊疽性膿皮症 ,  潰瘍 ,  日本人 ,  患者 ,  アダリムマブ ,  3相 ,  盲 ,  試験